Sahil Khanna, MBBS, MS, FACG

Mayo Clinic

Poster(s):

• D0099 - Efficacy and Safety of RBX2660 in Reducing Recurrent Clostridioides difficile Infection in Patients With Underlying Gastrointestinal Comorbidities
  Tuesday, October 25, 2022

  10:00 AM – 12:00 PM ET

• D0100 - Efficacy and Safety of RBX2660 in Patients After First Recurrence of Clostridioides difficile Infection – Results From a Phase 3, Randomized, Placebo-Controlled Study
  Tuesday, October 25, 2022

  10:00 AM – 12:00 PM ET